Navigation Links
Mylan Reports a 19% Increase in First Quarter 2013 Adjusted Diluted EPS to $0.62
Date:5/2/2013

three months ended March 31, 2013 as compared to adjusted earnings of $224.5 million for the prior year comparable period.

EBITDA, which is defined as net income (excluding the non-controlling interest and income from equity method investees) plus income taxes, interest expense, depreciation and amortization, was $350.5 million for the quarter ended March 31, 2013, and $368.5 million for the comparable prior year period. After adjusting for certain items as further detailed below, adjusted EBITDA was $443.4 million for the current three-month period and $411.2 million for the comparable prior year period. 

Cash Flow Adjusted cash provided by operating activities was $90 million for the three months ended March 31, 2013, compared to $69 million for the comparable prior year period. On a GAAP basis, cash provided by operating activities was $88 million for the three months ended March 31, 2013, compared to a cash usage of $107 million for the comparable prior year period. Capital expenditures were approximately $53 million in the current year as compared to approximately $36 million in the same prior year period.

During the three months ended March 31, 2013, the Company completed a share repurchase program by purchasing approximately 16.3 million shares of common stock for approximately $500 million.

Non-GAAP Financial Measures Mylan is disclosing non-GAAP financial measures when providing financial results. Primarily due to acquisitions, Mylan believes that an evaluation of its ongoing operations (and comparisons of its current operations with historical and future operations) would be difficult if the disclosure of its financial results were limited to financial measures prepared only in accordance with accounting principles generally accepted in the U.S. (GAAP). In addition to disclosing its financial results determined in accordance with GAAP, Mylan is disclosing certain non-GAAP results that exclude items such as amortiza
'/>"/>

SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Mylan Launches Generic Version of Zyprexa® Tablets
2. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement with Teva
3. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
4. Mylan Launches Generic Lipitor® in Five European Countries
5. Mylan Launches Generic Version of Plavix® Tablets
6. Mylan Sponsors Drug Store News and Pharmacist Society to Provide a New Business Networking Platform for Pharmacy Schools and Students
7. Mylan Launches Generic Version of Viramune® Tablets
8. Mylan Launches Generic Version of Bonviva® Film Coated Tablets in the UK and Italy
9. Mylan Announces Settlement Agreement in Patent Infringement Litigation Relating to Sunovions Brovana® Product
10. Mylan Announces Settlement Agreement in Litigation Relating to its Generic Xopenex®
11. Mylan Launches Generic Version of Lipitor®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... , Aug. 19, 2014 /PRNewswire-iReach/ -- ChemImage founder and ... a scientific poster describing an innovative diagnostic procedure for ... Shedding New Light on Disease (SPEC) conference in Krakow, ... Treado,s poster entitled, "Development of in vitro Diagnostics for ... be discussed during the conference poster session on Tuesday, ...
(Date:8/19/2014)... -- Tokyo-based Atonarp Inc. announced today $8 million in ... Riverwood Ventures with participation from other co-investors.  The ... technology platform, which will enable a broad range ... & gas and healthcare industries for its initial ... with Atonarp in pursuing the commercialization of its ...
(Date:8/19/2014)... – a provider-led accelerator that puts the power of ... ­– announces Sutter Health, a not-for-profit health system in ... recent addition to the AVIA Innovator Network. ... focused helping patients navigate the healthcare system and enable ... so they work as a larger team for each ...
Breaking Medicine Technology:ChemImage Scientists Present Latest Developments for in vitro Detection of Colorectal Cancer Using Raman Molecular Imaging (RMI) at International Conference Focused on Biomedical Applications of Raman Spectroscopy 2Atonarp Inc. Raises $8M Series A Round Led by Walden Riverwood Ventures 2AVIA and Sutter Health Join Forces to Address Healthcare's Most Pressing Challenges 2
... Md., Oct  27, 2011 Neuralstem, Inc. (NYSE Amex: ... in the ongoing safety trial to test its neuroregenerative small ... (MDD).  Phase Ia tested the drug in healthy volunteers for ... commence later this year, will test the safety and tolerability ...
... Oct. 27, 2011 Herborium Group, Inc., ... company, announced the following update today. ... stated: "These are truly exciting times for our Company. ... Bulletin Board exchange by maintaining Herborium, Current Information ...
Cached Medicine Technology:Neuralstem Completes Phase Ia in Neuroregenerative Small Molecule Drug, NSI-189, Major Depressive Disorder Trial 2Neuralstem Completes Phase Ia in Neuroregenerative Small Molecule Drug, NSI-189, Major Depressive Disorder Trial 3Herborium Group Shareholders Update 2Herborium Group Shareholders Update 3
(Date:8/20/2014)... This agreement will allow storageFOUNDRY ... networking, high availability cloud enablement, service, and elastic ... allowing OPEN-V to sell storageFOUNDRY’s expanding Nautilus line ... with OPEN-V on this distribution agreement of our ... channels at storageFOUNDRY. "Nautilus is a massively scalable, ...
(Date:8/19/2014)... well-known bamboo product manufacturer and retailer, has unveiled its new ... excited to reveal the new items, and it has decided ... every customer can get a discounted price, up to 30 ... , The company’s deckings are made of the finest quality, ... are perfect for a dining room, living room, kitchen, foyer, ...
(Date:8/19/2014)... Crosley Law Firm, PC has reached a confidential ... Star Bakery for an undisclosed amount. The two claimants, Pete ... of 2011, respectively. The injuries were caused by two different ... to the left hand of each man. , At the ... short-staffed, having lost 200 of its, 500 workers in connection ...
(Date:8/19/2014)... an outstanding company in the garment industry, has unveiled its ... to this, the company has also launched a big sale ... at low rates, up to 30 percent off. , ... bohemian outfits are available in many colours, including green, blush, ... quality clothes, reasonable prices and sincere service, the company has ...
(Date:8/19/2014)... the brain involved in multitasking and ways to train ... the IUGM Institut universitaire de griatrie de Montral and ... to better predict the effectiveness of this training. Cooking ... the Web, or driving while listening to a radio ... our daily lives. Unfortunately, it decreases with age, which ...
Breaking Medicine News(10 mins):Health News:storageFOUNDRY and Open-V OzoneStack Announce Bilateral Distribution Agreement 2Health News:storageFOUNDRY and Open-V OzoneStack Announce Bilateral Distribution Agreement 3Health News:Promotional Bamboo Deckings from Well-known Online Supplier BambooIndustry.com 2Health News:Crosley Law Firm Reaches Settlement for Hand Amputation Victims at Commercial Bakery 2Health News:2014 Bohemian Dresses Now for Sale at Skmen.com 2Health News:Targeted brain training may help you multitask better 2
... have found out why women who have a baby when ... breast cancer. They have identified a substance produced naturally in ... pregnancy trigger the changes in the breast tissue of young ... a pill that could protect against breast cancer. ...
... franchisee for US based Medicine Shoppe International, with operations in ... list of its target for operations in the country. According ... expand its franchisee operations from the present 19 outlets to ... decided to put on hold the commencing of operations in ...
... Common childhood vaccinations, including newer ones such as those ... diabetes. The conclusion came from a look at 768 ... had juvenile diabetes. Those who had been vaccinated against ... no more likely to have developed diabetes than those ...
... hormone production may help explain why obese people who carry ... a high risk of heart disease and other health problems. ... and its complications. // ,It is no news ... heart disease and diabetes, but where these extra pounds accumulate ...
... some time that a wide range of influenza viruses circulate in ... humans. These are two subtypes of the influenza A virus known ... was reported in Hong Kong in mid-May . ,The ... six people and infect 12 others in a small but densely ...
... may not only an effective treatment for malaria, the ... be similar to the mechanism they use to ... these findings at the 50th Annual Meeting of the ... ,The compounds called disulfides, occur naturally in garlic, ...
Cached Medicine News:
... Tips are available as both regular and ... by gamma-rays for more efficient sterilization and ... specifying the date of irradiation. Sterilized Diamond ... to autoclave. SterilPack Diamond Tips are wrapped ...
This large 1000 L tip makes pipetting fragile cells, genomic DNA, and viscous samples easy. Perfect for cell culture laboratories....
This 1000 L tip is the equivalent to the "Blue" tips and fits nearly every manufacturer's 1000 L pipettor....
Conducting disposable filter-tips....
Medicine Products: